Ambala Court Awaits Jeff Bezos and Amazon Appearance in Patanjali Bala Churna NDPS Case
In a significant development in the ongoing Bala Churna case, the court of Chief Judicial Magistrate Gitanjali Goel in Ambala has noted that the presence of Amazon founder Jeffrey Preston Bezos and the e-commerce giant Amazon is still pending. The court has now scheduled May 20 as the next date for their mandatory appearance, marking a crucial step in this high-profile legal proceeding.
Notices Issued to Amazon India Leadership
Simultaneously, the court has issued a formal notice to Amit Agarwal, the senior vice-president and country manager of Amazon India based in Bengaluru. He has been directed to appear in person on the next hearing date, emphasizing the court's insistence on accountability from the company's top executives in India.
Other Respondents Comply with Court Directives
Meanwhile, all other remaining respondents in the case, including prominent figures such as Baba Ramdev and Acharya Balkrishna from Patanjali, have appeared before the court through their legal counsel. The court has directed them to file their detailed replies by May 20, ensuring that all parties are actively engaged in the judicial process.
Background of the Bala Churna Case
The case stems from a serious complaint alleging that Patanjali's Divya Pharmacy product, Bala Churna, contained controlled substances in violation of the stringent provisions under the Narcotic Drugs and Psychotropic Substances (NDPS) Act and other relevant laws. This has raised significant concerns about product safety and regulatory compliance in the health supplement industry.
Origins and Previous Court Actions
Earlier, the court had issued summons to a total of 14 individuals, including Baba Ramdev, Acharya Balkrishna, and Jeffrey Bezos. This action was initiated in connection with a complaint filed by Ambala-based athlete Deepak Sandhu on November 5, 2024. The complainant alleged that his health deteriorated significantly after consuming the Bala Churna product, which he had purchased online via the Amazon platform.
The case highlights critical issues at the intersection of e-commerce, health products, and legal accountability, with the next hearing on May 20 poised to be a pivotal moment in determining the involvement and responsibilities of all parties, including global corporate entities like Amazon.
